Cefotetan (BioDeep_00000006368)

 

Secondary id: BioDeep_00001868198

human metabolite blood metabolite Chemicals and Drugs


代谢物信息卡片


(6R,7S)-7-{4-[carbamoyl(carboxy)methylidene]-1,3-dithietane-2-amido}-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

化学式: C17H17N7O8S4 (575.0021442)
中文名称: 头孢替坦
谱图信息: 最多检出来源 Homo sapiens(blood) 94.74%

分子结构信息

SMILES: CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O
InChI: InChI=1S/C17H17N7O8S4/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28/h13,15H,3-4H2,1-2H3,(H2,18,25)(H,19,26)(H,27,28)(H,29,30)/t13?,15-,17+/m1/s1

描述信息

Cefotetan is only found in individuals that have used or taken this drug. It is a semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. [PubChem]The bactericidal action of cefotetan results from inhibition of cell wall synthesis by binding and inhibiting the bacterial penicillin binding proteins which help in the cell wall biosynthesis.
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002513 - Cephamycins
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

同义名列表

8 个代谢物同义名

(6R,7S)-7-{4-[carbamoyl(carboxy)methylidene]-1,3-dithietane-2-amido}-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5- yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid; (6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5- yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylate; cefotetan disodium; Cefotetanum; Cefotetan; DB-055329; CTT



数据库引用编号

17 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Jian Liu, You Zhai, Lihua Wu, Guolan Wu, Yunliang Zheng, Xingjiang Hu, Jianzhong Shentu. Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers. Drug design, development and therapy. 2020; 14(?):613-620. doi: 10.2147/dddt.s234619. [PMID: 32103903]
  • Ken Grime, Stuart W Paine. Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement. Drug metabolism and disposition: the biological fate of chemicals. 2013 Feb; 41(2):372-8. doi: 10.1124/dmd.112.049312. [PMID: 23139379]
  • Yani Liu, Jiangeng Huang, Jinmei Liu, Lin Ma, Yongning Lv, Shaojun Shi. A simple and sensitive liquid chromatographic technique for the determination of cefotetan disodium in human plasma and its application in a pharmacokinetic study. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban. 2012 Oct; 32(5):779-784. doi: 10.1007/s11596-012-1034-2. [PMID: 23073813]
  • George Garratty. Immune hemolytic anemia caused by drugs. Expert opinion on drug safety. 2012 Jul; 11(4):635-42. doi: 10.1517/14740338.2012.678832. [PMID: 22502777]
  • Xiao-ling Liu, Dai-zhi Peng, Liang Xue, Wen-ting Shu, Xin Zhou, Jing Liu. [Analysis of resistance phenotype and homology of Klebsiella pneumoniae in burn patients]. Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns. 2012 Apr; 28(2):96-100. doi: . [PMID: 22781319]
  • Izabela Korona-Glowniak, Ewelina Grywalska, Beata Chudzik, Agnieszka Bojarska-Junak, Anna Malm, Jacek Rolinski. Upper respiratory tract colonization by gram-negative rods in patients with chronic lymphocytic leukemia: analysis of risk factors. TheScientificWorldJournal. 2012; 2012(?):617218. doi: 10.1100/2012/617218. [PMID: 22606052]
  • Meng-xiang Su, Min-hong Liu, Bin Di, Li-li Huang, Yuan Jiang, Peng-cheng Ma, Tai-jun Hang. Pharmacokinetic differences between the epimers of cefotetan disodium after single intravenous injection in healthy Chinese volunteers. European journal of drug metabolism and pharmacokinetics. 2011 Dec; 36(4):223-8. doi: 10.1007/s13318-011-0064-7. [PMID: 21915733]
  • Woo Hyuk Jang, Dong Hoon Yoo, Seong Woon Park. Prevalence of and Risk Factors for Levofloxacin-Resistant E. coli Isolated from Outpatients with Urinary Tract Infection. Korean journal of urology. 2011 Aug; 52(8):554-9. doi: 10.4111/kju.2011.52.8.554. [PMID: 21927703]
  • Kyoung Ho Ryu, Yun Beom Kim, Seung Ok Yang, Jeong Kee Lee, Tae Young Jung. Results of urine culture and antimicrobial sensitivity tests according to the voiding method over 10 years in patients with spinal cord injury. Korean journal of urology. 2011 May; 52(5):345-9. doi: 10.4111/kju.2011.52.5.345. [PMID: 21687395]
  • Ghan-Shyam Lohiya, Lilia Tan-Figueroa, Vamsi Krishna. Piperacillin-induced immune hemolysis presenting with tachycardia and cardiac arrest. Case reports in medicine. 2011; 2011(?):816497. doi: 10.1155/2011/816497. [PMID: 22235207]
  • Mohammad K Moslemi, Seyed M Moosavi Movahed, Akram Heidari, Hossein Saghafi, Mehdi Abedinzadeh. Comparative evaluation of prophylactic single-dose intravenous antibiotic with postoperative antibiotics in elective urologic surgery. Therapeutics and clinical risk management. 2010 Nov; 6(?):551-6. doi: 10.2147/tcrm.s12512. [PMID: 21151625]
  • Shaojun Shi, Yani Liu, Zhongfang Li, Heng Zheng, Yongning Lv, Hui Chen. Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study. Clinical therapeutics. 2010 Sep; 32(10):1832-41. doi: 10.1016/j.clinthera.2010.09.015. [PMID: 21194607]
  • Chung Hyun Tae, Sung-Ae Jung, Hyun Joo Song, Seong-Eun Kim, Hee Jung Choi, Miae Lee, Yusun Hwang, Heejung Kim, Kyungwon Lee. The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. Journal of Korean medical science. 2009 Jun; 24(3):520-4. doi: 10.3346/jkms.2009.24.3.520. [PMID: 19543521]
  • George Garratty. Drug-induced immune hemolytic anemia. Hematology. American Society of Hematology. Education Program. 2009; ?(?):73-9. doi: 10.1182/asheducation-2009.1.73. [PMID: 20008184]
  • Paul Suding, Erin Jensen, Murray A Abramson, Kamal Itani, Samuel Eric Wilson. Definitive risk factors for anastomotic leaks in elective open colorectal resection. Archives of surgery (Chicago, Ill. : 1960). 2008 Sep; 143(9):907-11; discussion 911. doi: 10.1001/archsurg.143.9.907. [PMID: 18794430]
  • R Scott Obach, Franco Lombardo, Nigel J Waters. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals. 2008 Jul; 36(7):1385-405. doi: 10.1124/dmd.108.020479. [PMID: 18426954]
  • Yukio Kato, Seiko Takahara, Sayaka Kato, Yoshiyuki Kubo, Yoshimichi Sai, Ikumi Tamai, Hikaru Yabuuchi, Akira Tsuji. Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics. Drug metabolism and disposition: the biological fate of chemicals. 2008 Jun; 36(6):1088-96. doi: 10.1124/dmd.107.019125. [PMID: 18339814]
  • Mansour Al-Zarouni, Abiola Senok, Fatima Rashid, Shaikha Mohammed Al-Jesmi, Debadatta Panigrahi. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2008; 17(1):32-6. doi: 10.1159/000109587. [PMID: 18059098]
  • Johann D D Pitout, Daniel B Gregson, Deirdre L Church, Kevin B Laupland. Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerging infectious diseases. 2007 Mar; 13(3):443-8. doi: 10.3201/eid1303.060447. [PMID: 17552098]
  • C Moubareck, F Gavini, L Vaugien, M J Butel, F Doucet-Populaire. Antimicrobial susceptibility of bifidobacteria. The Journal of antimicrobial chemotherapy. 2005 Jan; 55(1):38-44. doi: 10.1093/jac/dkh495. [PMID: 15574479]
  • Robertson D Davenport, W John Judd, Louann R Dake. Persistence of cefotetan on red blood cells. Transfusion. 2004 Jun; 44(6):849-52. doi: 10.1111/j.1537-2995.2004.03360.x. [PMID: 15157250]
  • A Scott Mathis, Nisha Davé, Nita K Shah, Gary S Friedman. Bleeding and thrombosis in high-risk renal transplantation candidates using heparin. The Annals of pharmacotherapy. 2004 Apr; 38(4):537-43. doi: 10.1345/aph.1d510. [PMID: 14766999]
  • Massimo Franchini, Pier Luigi Piccoli, Giorgio Gandini, Annachiara Giuffrida, Fausto Bressan, Marzia De Gironcoli, Giuseppe Aprili. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia. Hematology (Amsterdam, Netherlands). 2004 Feb; 9(1):65-9. doi: 10.1080/10245330310001638956. [PMID: 14965871]
  • S Shariatmadar, J R Storry, L Sausais, M E Reid. Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery. Immunohematology. 2004; 20(1):63-6. doi: 10.21307/immunohematology-2019-423. [PMID: 15373671]
  • Yutaka Shiraki, Naohiro Shibata, Yohei Doi, Yoshichika Arakawa. Escherichia coli producing CTX-M-2 beta-lactamase in cattle, Japan. Emerging infectious diseases. 2004 Jan; 10(1):69-75. doi: 10.3201/eid1001.030219. [PMID: 15078599]
  • William W Andrews, John C Hauth, Suzanne P Cliver, Karen Savage, Robert L Goldenberg. Randomized clinical trial of extended spectrum antibiotic prophylaxis with coverage for Ureaplasma urealyticum to reduce post-cesarean delivery endometritis. Obstetrics and gynecology. 2003 Jun; 101(6):1183-9. doi: 10.1016/s0029-7844(03)00016-4. [PMID: 12798523]
  • Cecilia M Rosales, Matthew D McLaughlin, Tetsutaro Sata, Harutaka Katano, Pat A Veno, Luis E de Las Casas, Roberto N Miranda. AIDS presenting with cutaneous Kaposi's sarcoma and bacillary angiomatosis in the bone marrow mimicking Kaposi's sarcoma. AIDS patient care and STDs. 2002 Dec; 16(12):573-7. doi: 10.1089/108729102761882107. [PMID: 12542930]
  • Patricia A Arndt, George Garratty. Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin. American journal of clinical pathology. 2002 Aug; 118(2):256-62. doi: 10.1309/jfje-vukn-221t-g6ev. [PMID: 12162687]
  • Roopa Viraraghavan, Aloka G Chakravarty, Janice Soreth. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adverse drug reactions and toxicological reviews. 2002; 21(1-2):101-7. doi: 10.1007/bf03256184. [PMID: 12140903]
  • H Thadepalli, S K Chuah, S Qazi, F Thadepalli, S V Gollapudi. Bacteroides fragilis-induced intra-abdominal abscess in an experimental model treated with telithromycin (HMR 3647). Chemotherapy. 2001 Jan; 47(1):43-9. doi: 10.1159/000048500. [PMID: 11125232]
  • G S Moes, B R MacPherson. Cefotetan-induced hemolytic anemia: a case report and review of the literature. Archives of pathology & laboratory medicine. 2000 Sep; 124(9):1344-6. doi: 10.5858/2000-124-1344-ciha. [PMID: 10975934]
  • D Stroncek, J L Procter, J Johnson. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction. American journal of hematology. 2000 May; 64(1):67-70. doi: 10.1002/(sici)1096-8652(200005)64:1<67::aid-ajh12>3.0.co;2-z. [PMID: 10815791]
  • R M Leger, P A Arndt, D J Ciesielski, G Garratty. False-positive eluate reactivity due to the low-ionic wash solution used with commercial acid-elution kits. Transfusion. 1998 Jun; 38(6):565-72. doi: 10.1046/j.1537-2995.1998.38698326336.x. [PMID: 9661690]
  • F Scarpellini, L Scarpellini, M Sbracia, C Curto. Effectiveness of a cephalosporin, cefotetan, in inhibition of uterine matrix metalloproteinases by a non-antibacterial mechanism. Annals of the New York Academy of Sciences. 1994 Sep; 732(?):495-6. doi: 10.1111/j.1749-6632.1994.tb24797.x. [PMID: 7978850]
  • C Martin, L Thomachot, J Albanese. Clinical pharmacokinetics of cefotetan. Clinical pharmacokinetics. 1994 Apr; 26(4):248-58. doi: 10.2165/00003088-199426040-00002. [PMID: 8013159]
  • S W Petersen, E Rosin. In vitro antibacterial activity of cefoxitin and cefotetan and pharmacokinetics in dogs. American journal of veterinary research. 1993 Sep; 54(9):1496-9. doi: NULL. [PMID: 8239139]
  • M Yamamoto, M Jimbo, M Ide, N Tanaka, Y Umebara, S Hagiwara. Penetration of intravenous antibiotics into brain abscesses. Neurosurgery. 1993 Jul; 33(1):44-9. doi: 10.1227/00006123-199307000-00007. [PMID: 8102792]
  • P Cherrier, P Perrin, S Gueye, A M Bosio, P Tinel, P Blot, R Richer, F Fauvelle. Pharmacokinetics and clinical study of cefotetan in bile: prophylactic use in biliary tract surgery. Pharmacy world & science : PWS. 1993 Apr; 15(2):79-82. doi: 10.1007/bf01874087. [PMID: 8490588]
  • F de Lalla, S Scalambrino, P G Tassi, G Alegente, R Conturso, L Doregatti, L Archetti, F Pollini, G C Zanella, E Demaria. Piperacillin versus cefotetan as single-dose prophylaxis in abdominal hysterectomy: a prospective, randomized, multicenter study. Journal of chemotherapy (Florence, Italy). 1993 Apr; 5(2):113-8. doi: 10.1080/1120009x.1993.11739218. [PMID: 8515293]
  • C E Chenoweth, W J Judd, E A Steiner, C A Kauffman. Cefotetan-induced immune hemolytic anemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1992 Nov; 15(5):863-5. doi: 10.1093/clind/15.5.863. [PMID: 1445986]
  • C Martin, C Portet, D Lambert, B Bruguerolle, B Sastre, P De Micco, F Gouin. Pharmacokinetics and tissue penetration of single-dose cefotetan used for antimicrobial prophylaxis in patients undergoing colorectal surgery. Antimicrobial agents and chemotherapy. 1992 May; 36(5):1115-8. doi: 10.1128/aac.36.5.1115. [PMID: 1510402]
  • G Garratty, S Nance, M Lloyd, R Domen. Fatal immune hemolytic anemia due to cefotetan. Transfusion. 1992 Mar; 32(3):269-71. doi: 10.1046/j.1537-2995.1992.32392213813.x. [PMID: 1557811]
  • K Saionji, N Miyake, K Miyake, J Igari, I Kobayashi, Y Satoh. [Free concentration and protein binding of ceftriaxone]. The Japanese journal of antibiotics. 1992 Feb; 45(2):136-42. doi: NULL. [PMID: 1613966]
  • R J Schwartz, T J Dubrow, R A Rival, S E Wilson, R A Williams. The effect of fibrin glue on intraperitoneal contamination in rats treated with systemic antibiotics. The Journal of surgical research. 1992 Feb; 52(2):123-6. doi: 10.1016/0022-4804(92)90291-7. [PMID: 1740933]
  • C J Ablan, R N Olen, P B Dobrin, P O'Keefe, W Tatarowicz, R J Freeark. Efficacy of intraperitoneal antibiotics in the treatment of severe fecal peritonitis. American journal of surgery. 1991 Nov; 162(5):453-6. doi: 10.1016/0002-9610(91)90259-g. [PMID: 1951908]
  • M B Kays, R L White, L V Friedrich, V E Del Bene. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties. Clinical therapeutics. 1991 Sep; 13(5):596-605. doi: NULL. [PMID: 1799917]
  • C W Kaiser, J D McAuliffe, R J Barth, J A Lynch. Hypoprothrombinemia and hemorrhage in a surgical patient treated with cefotetan. Archives of surgery (Chicago, Ill. : 1960). 1991 Apr; 126(4):524-5. doi: 10.1001/archsurg.1991.01410280128021. [PMID: 1901205]
  • L S Welage, M T Borin, J H Wilton, L G Hejmanowski, P B Wels, J J Schentag. Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazole. Antimicrobial agents and chemotherapy. 1990 Dec; 34(12):2369-74. doi: 10.1128/aac.34.12.2369. [PMID: 2088192]
  • H Matsushita, H Suzuki, Y Sugiyama, Y Sawada, T Iga, M Hanano, Y Kawaguchi. Prediction of the pharmacokinetics of cefodizime and cefotetan in humans from pharmacokinetic parameters in animals. Journal of pharmacobio-dynamics. 1990 Oct; 13(10):602-11. doi: 10.1248/bpb1978.13.602. [PMID: 2095400]
  • G C Oliva, A Fratoni, L Papadia, A Pieroni, P L Paparella, S Mancuso. Antibiotic prophylaxis in gynecological surgery. Journal of chemotherapy (Florence, Italy). 1990 Oct; 2(5):306-9. doi: 10.1080/1120009x.1990.11739034. [PMID: 2090769]
  • V D Nguyen, H Nagelberg, B N Agarwal. Acute interstitial nephritis associated with cefotetan therapy. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1990 Sep; 16(3):259-61. doi: 10.1016/s0272-6386(12)81027-4. [PMID: 2399919]
  • C Martin, M N Mallet, D Lambert, J P Brun, C Yrieix, D Bruguerolle, B Sastre. [Tissue penetration of single-dose cefotetan used for antibiotic prophylaxis in colorectal surgery]. Pathologie-biologie. 1990 Jun; 38(5 ( Pt 2)):500-3. doi: NULL. [PMID: 2143572]
  • M Cruciani, A Navarra, L Bono, E Concia. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan. Journal of chemotherapy (Florence, Italy). 1989 Jul; 1(4 Suppl):101-2. doi: NULL. [PMID: 16312323]
  • L S Mauro, V F Mauro, P C Miller, D A Lacher. Effect of cefotetan on creatinine determination by the picric acid and enzymatic methods. Clinical pharmacy. 1989 Jul; 8(7):505-8. doi: NULL. [PMID: 2752700]
  • L S Welage, L G Hejmanowski, J H Wilton, C Walawander, D Rigan, J S Williams, J J Schentag. Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan. Antimicrobial agents and chemotherapy. 1989 Jun; 33(6):857-61. doi: 10.1128/aac.33.6.857. [PMID: 2764537]
  • J Zimmerman, A Cohen, P Thyrum. Absolute bioavailability and noncompartmental analysis of intravenous and intramuscular Cefotan (cefotetan) in normal volunteers. Journal of clinical pharmacology. 1989 Feb; 29(2):151-7. doi: 10.1002/j.1552-4604.1989.tb03304.x. [PMID: 2715372]
  • P L Carver, C H Nightingale, R Quintiliani. Pharmacokinetics and pharmacodynamics of total and unbound cefoxitin and cefotetan in healthy volunteers. The Journal of antimicrobial chemotherapy. 1989 Jan; 23(1):99-106. doi: 10.1093/jac/23.1.99. [PMID: 2745258]
  • D J Christie, S S Lennon, R L Drew, C D Swinehart. Cefotetan-induced immunologic thrombocytopenia. British journal of haematology. 1988 Dec; 70(4):423-6. doi: 10.1111/j.1365-2141.1988.tb02511.x. [PMID: 3219293]
  • P Kujath, W Düsel, H P Bruch, F Kees. The pharmacokinetic properties of cefotetan and its relevance for prophylaxis in elective colorectal surgery. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. 1988 Aug; 7(4):229-32. doi: . [PMID: 3180301]
  • J R Edwards. Cefotetan: antibacterial activity against Staphylococcus aureus in the presence of human serum. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. 1988 Aug; 7(4):271-3. doi: . [PMID: 3180308]
  • M Cruciani, A Navarra, L Bono, E Concia. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. 1988 Aug; 7(4):261-3. doi: NULL. [PMID: 3180306]
  • K Engel, W Schmidt, H G Sonntag, F Kees. Comparative clinical and pharmacokinetic aspects of cefotetan versus cefoxitin plus metronidazole in vaginal hysterectomy. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. 1988 Aug; 7(4):256-60. doi: NULL. [PMID: 3052894]
  • P Cristiano, R Lobello, M R Iovene, G De Ascentis, P Altucci, F Paradisi, L Manguso. Clinical and pharmacokinetic study of cefotetan in biliary tract infections: preliminary report. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. 1988 Aug; 7(4):233-6. doi: NULL. [PMID: 3180302]
  • S Nakano, H Yada, K Irimura, K Kurokawa, T Hirota, K Morita. [Five-week subacute intravenous toxicity study of cefodizime sodium in dogs]. The Journal of toxicological sciences. 1988 Jun; 13 Suppl 1(?):43-90. doi: 10.2131/jts.13.supplementi_43. [PMID: 3172296]
  • D G Jagelman, T C Fabian, R L Nichols, H H Stone, S E Wilson, S R Zellner. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery. American journal of surgery. 1988 May; 155(5A):71-6. doi: 10.1016/s0002-9610(88)80217-4. [PMID: 3287972]
  • R P Galask, B B Benigno, F G Cunningham, J P Elliott, E Makowski, J A McGregor, A Poindexter. Results of a multicenter comparative study of single-dose cefotetan and multiple-dose cefoxitin as prophylaxis in patients undergoing cesarean section. American journal of surgery. 1988 May; 155(5A):86-90. doi: 10.1016/s0002-9610(88)80220-4. [PMID: 3287975]
  • D E Fry. Cefotetan: a perspective for the surgical patient. American journal of surgery. 1988 May; 155(5A):108-10. doi: 10.1016/s0002-9610(88)80225-3. [PMID: 3163899]
  • R Quintiliani, C H Nightingale, R C Stevens, W R Outman, P J Deckers, M G Martens. Comparative pharmacokinetics of cefotetan and cefoxitin in patients undergoing hysterectomies and colorectal operations. American journal of surgery. 1988 May; 155(5A):67-70. doi: 10.1016/s0002-9610(88)80216-2. [PMID: 3163902]
  • M Imaizumi, T Niimi, T Uchida, M Kajita, T Takahashi, Y Uchida, M Asaoka, Y Amano, T Ojika, T Abe. [Clinical study on transfer into lung tissue and postoperative prophylactic effect of new cephamycin antibiotics, particularly cefotetan and cefbuperazone]. The Japanese journal of antibiotics. 1988 Apr; 41(4):437-59. doi: NULL. [PMID: 3165475]
  • R T Lewis, R J Duma, R M Echols, J G Jemsek, A Z Najem, R A Press, H H Stone, G T Ton, S E Wilson. Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections. American journal of obstetrics and gynecology. 1988 Mar; 158(3 Pt 2):728-35. doi: 10.1016/s0002-9378(16)44536-9. [PMID: 3281463]
  • J W Orr, P F Sisson, J M Barrett, J R Ellington, R H Jennings, D L Taylor. Pharmacokinetics and tissue kinetics of 1 gm cefotetan prophylaxis in abdominal or vaginal hysterectomy. American journal of obstetrics and gynecology. 1988 Mar; 158(3 Pt 2):742-3. doi: 10.1016/s0002-9378(16)44538-2. [PMID: 3162654]
  • J A Stanfield, J T DiPiro. Interference of cefmetazole sodium and cefotetan disodium with urine-glucose testing systems. American journal of hospital pharmacy. 1988 Mar; 45(3):625-6. doi: 10.1093/ajhp/45.3.625. [PMID: 3163470]
  • H Cohen, S D Scott, I J Mackie, M Shearer, R Bax, S J Karran, S J Machin. The development of hypoprothrombinaemia following antibiotic therapy in malnourished patients with low serum vitamin K1 levels. British journal of haematology. 1988 Jan; 68(1):63-6. doi: 10.1111/j.1365-2141.1988.tb04180.x. [PMID: 3422816]
  • F Fraschini, F Scaglione, M Mezzetti, M Meroni, F Cicchetti, P Scarpazza, G Scarpazza. Pharmacokinetic profile of cefotetan in different clinical conditions. Drugs under experimental and clinical research. 1988; 14(8):547-53. doi: NULL. [PMID: 3248508]
  • S Ripa, F Mignini, M Prenna. Pharmacokinetics of cefotetan in elderly subjects after intramuscular administration. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. 1987 Oct; 6(5):359-63. doi: NULL. [PMID: 3480780]
  • S S Kline, V F Mauro, R B Forney, E H Freimer, P Somani. Cefotetan-induced disulfiram-type reactions and hypoprothrombinemia. Antimicrobial agents and chemotherapy. 1987 Sep; 31(9):1328-31. doi: 10.1128/aac.31.9.1328. [PMID: 3479045]
  • H Cohen, I J Mackie, K Walshe, M Shearer, R Bax, A Pozniak, M Moulsdale, S J Machin. The effects of cefotetan disodium on haemostasis. The Journal of hospital infection. 1987 Jul; 10(1):51-7. doi: 10.1016/0195-6701(87)90032-6. [PMID: 2888812]
  • I J Mackie, K Walshe, H Cohen, P McCarthy, M Shearer, S D Scott, S J Karran, S J Machin. Effects of N-methyl-thiotetrazole cephalosporin on haemostasis in patients with reduced serum vitamin K1 concentrations. Journal of clinical pathology. 1986 Nov; 39(11):1245-9. doi: 10.1136/jcp.39.11.1245. [PMID: 3466904]
  • Y Matsumoto, Y Hitsuda, Y Sugimoto, J Ishikawa, T Sasaki. [Serum and sputum levels of cefotetan used in respiratory tract infections]. The Japanese journal of antibiotics. 1986 Oct; 39(10):2690-4. doi: NULL. [PMID: 3468274]
  • M J Browning, H A Holt, L O White, S T Chapman, R A Banks, D S Reeves, R A Yates. Pharmacokinetics of cefotetan in patients with end-stage renal failure on maintenance dialysis. The Journal of antimicrobial chemotherapy. 1986 Jul; 18(1):103-6. doi: 10.1093/jac/18.1.103. [PMID: 3463556]
  • J Gaillat, J Croize, J P Bru, J P Stahl, P Le Noc, M Micoud. [Cefotetan: clinical trial in elderly persons using a single daily dose of 2 grams as the sole therapy]. Pathologie-biologie. 1986 May; 34(5):461-4. doi: . [PMID: 3534722]
  • B R Smith, J L LeFrock, P T Thyrum, B A Doret, C Yeh, G Onesti, A Schwartz, J J Zimmerman. Cefotetan pharmacokinetics in volunteers with various degrees of renal function. Antimicrobial agents and chemotherapy. 1986 May; 29(5):887-93. doi: 10.1128/aac.29.5.887. [PMID: 3460524]
  • H Sugiyama, T Hatano, K Takayanagi, H Aoyama, Y Kikuchi. [Transfer of cefotetan into exudates from excoriated skin wounds]. The Japanese journal of antibiotics. 1986 May; 39(5):1297-301. doi: NULL. [PMID: 3463777]
  • O Daghero, G Andreoni, R Arione, L Bendiscioli, C Bramato, T Cimino, B Salassa, C Spezia, M L Soranzo. [Cephalosporins and enzymuria]. Minerva medica. 1986 Feb; 77(7-8):231-7. doi: NULL. [PMID: 2869451]
  • B Trollfors, R Norrby, J Bergmark, B Hultberg, H Linderholm. Comparative toxicity of gentamicin and cefotetan. Scandinavian journal of infectious diseases. 1986; 18(2):139-46. doi: 10.3109/00365548609032320. [PMID: 3518049]
  • Y Kumasaka, H Nakahata, Y Hirai, K Imamura, K Takebe, I Suzuki, H Senda. [In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes]. The Japanese journal of antibiotics. 1986 Jan; 39(1):154-8. doi: NULL. [PMID: 3517405]
  • K Schulte-Mattler, I Fink-Schneider, E Tiesler. [Cefotetan in the treatment of sinusitis--a kinetic study]. HNO. 1985 Dec; 33(12):545-7. doi: NULL. [PMID: 3866759]
  • A Ward, D M Richards. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1985 Nov; 30(5):382-426. doi: 10.2165/00003495-198530050-00002. [PMID: 3905336]
  • K Fujita, T Sayama, S Abe, T Murayama, M Sugimoto, T Hara. [A pharmacokinetic study of antibiotics in patients with benign prostatic hypertrophy]. The Japanese journal of antibiotics. 1985 Aug; 38(8):2145-8. doi: NULL. [PMID: 2416961]
  • H Saito, K Sato, B W Jin. Activities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in mice. Antimicrobial agents and chemotherapy. 1984 Aug; 26(2):270-1. doi: 10.1128/aac.26.2.270. [PMID: 6592999]
  • F Kees, H Grobecker, K G Naber. High-performance liquid chromatographic analysis of cefotetan epimers in human plasma and urine. Journal of chromatography. 1984 Feb; 305(2):363-71. doi: 10.1016/s0378-4347(00)83350-2. [PMID: 6584433]
  • H M Just, E E Petersen, M Bassler, U Frank, F D Daschner. Penetration of cefotetan into serum, myometrium, endometrium and salpinges. Chemotherapy. 1984; 30(5):305-7. doi: 10.1159/000238285. [PMID: 6593163]
  • F Di Nola. [Update on antibiotic therapy. 19) Cefotetan]. Minerva medica. 1983 Nov; 74(43):2653-8. doi: NULL. [PMID: 6379515]
  • J Yasuda, T Yamamoto, M Itoh, H Honjo, H Okada, M Kanao. [Evaluation of cefotetan in obstetrics and gynecology]. The Japanese journal of antibiotics. 1983 Sep; 36(9):2455-60. doi: NULL. [PMID: 6581342]
  • R Wise, I A Donovan, J Drumm, J Dent, S A Bennett. Intraperitoneal penetration of cefotetan. Antimicrobial agents and chemotherapy. 1983 Aug; 24(2):279-81. doi: 10.1128/aac.24.2.279. [PMID: 6579881]
  • M L Soranzo, E Capra, M Eandi, G C Angela, E Musso, L Bendiscioli, B Salassa, M Braida, P Lollini, L Pizzo, G Cignolo, C Spezia, G Andreoni, C Bramato, F di Nola. [Microbiological, kinetic and clinical study on a new cephamycin: cefotetan]. Minerva medica. 1983 Jun; 74(27):1639-50. doi: NULL. [PMID: 6343925]
  • R Fujii, H Meguro, H Yoshioka, K Fujita, S Maruyama, N Sanae, I Nagamatsu, A Okuno, Y Izumi, R Aoyama. [Comprehensive evaluation of cefotetan in pediatrics]. The Japanese journal of antibiotics. 1983 Jun; 36(6):1173-84. doi: . [PMID: 6361309]
  • S Nakazawa, H Sato, K Niino, H Suzuki, S Nakazawa, H Chikaoka, S Oka, Y Hirama, A Narita. [Experimental and clinical evaluation of a new cephamycin antibiotic, cefotetan, in pediatrics]. The Japanese journal of antibiotics. 1983 Jun; 36(6):1219-32. doi: . [PMID: 6581328]
  • N Iwai, A Sasaki, Y Taneda, F Mizoguchi, H Nakamura. [Experimental and clinical evaluation of cefotetan in pediatrics]. The Japanese journal of antibiotics. 1983 Jun; 36(6):1279-94. doi: . [PMID: 6581333]